Paclitaxel 6 mg/mL (Paclitaxel INJECTION, SOLUTION, CONCENTRATE) 6 mg/mL

Paclitaxel 6 mg/mL is a concentrated solution for intravenous use, commonly associated with cancer treatment protocols. This multi-dose injection is manufactured by Teva Parenteral Medicines, Inc. in the USA.

Strength

6 mg/mL

Pack Size

1 VIAL, MULTI-DOSE in 1 CARTON (0703-3217-01) / 25 mL in 1 VIAL, MULTI-DOSE

Manufacturer / TM Owner

Teva Parenteral Medicines, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Paclitaxel 6 mg/mL is primarily used in the management of various types of cancer. It is often included in chemotherapy regimens to target rapidly dividing cancer cells. The specific uses of Paclitaxel may vary depending on individual treatment plans and medical conditions.

Side Effects

Paclitaxel 6 mg/mL may cause common side effects such as fatigue, nausea, and hair loss. These effects can vary in intensity and duration among individuals. It is important to discuss potential side effects with a healthcare provider before starting treatment.

Precautions & Warnings

Paclitaxel 6 mg/mL should be handled with care, as it is a potent medication. It is essential to follow proper storage and administration guidelines to ensure safety. Always consult a healthcare professional for personalized advice.

Avoid Interactions

Paclitaxel 6 mg/mL may interact with other medications, including those that affect liver function or blood cell counts. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions.

Frequently Asked Questions

Paclitaxel 6 mg/mL is commonly used in cancer treatment protocols to target rapidly dividing cancer cells.

Paclitaxel 6 mg/mL is administered intravenously, typically in a clinical setting under the supervision of a healthcare professional.

Common side effects may include fatigue, nausea, and hair loss. Individual experiences can vary.

Paclitaxel 6 mg/mL may interact with other medications, so it is important to consult a healthcare provider before combining treatments.

Paclitaxel 6 mg/mL should be stored according to the manufacturer's guidelines to maintain its efficacy and safety.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.